期刊文献+

292例胎儿生长受限相关危险因素分析 被引量:2

Analysis of the correlative factors of fetal growth restriction
原文传递
导出
摘要 目的探讨胎儿生长受限(FGR)发生的相关因素,达到早发现、早诊断、早治疗,预防FGR的合并症及并发症。方法对292例FGR病例进行回顾性分析。结果292例中母体因素87例(29.8%),胎儿因素18例(6.2%),胎盘因素17例(5.8%),脐带因素58例(19.9%),无明确原因112例(38.0%);阴道分娩组新生儿窒息24例,占41.4%,剖宫产组新生儿窒息24例,占10.3%,两组分娩方式差异有统计学意义。结论FGR的主要病因是母体因素,及时恰当地治疗妊娠合并症和并发症,适当放宽剖宫产指征,有利于降低FGR的后遗症。 Objective To discuss the correlative factors of fetal growth restriction(FGR) in order to earlier detect, earlier diagnose, earlier treat FGR and prevent the complications and subsequent syndrome of FGR. Methods 292 cases of FGR were retrospectively analyzed during the last several years in our hospital. Results Among 292 cases of FGR, 87 (29.8 % ) had maternal factor, 18 (6.2 % ) had fetal factor, 17 (5.8 % ) had placental factor, 58 (19.9 % ) had umbilical cord factor, 112 (38.0 % ) had unknown. In vagina childbirth group, newborn asphyxia was 24(41.4 % ), and in c-section group, there was 24 (10.3 % ). There was significant difference between them. Conclusion The main cause of FGR is maternal factor. Treating the complications and subsequent syndrome of pregnance timely and rightly, broadening the refers drafts of c-section properly would be advantageous in reducing the sequelas of FGR.
作者 贾金平
出处 《中国基层医药》 CAS 2006年第8期1288-1290,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 胎儿生长受限 危险因素 Fetal growth restriction Dangerous factors
  • 相关文献

参考文献4

二级参考文献1

共引文献152

同被引文献27

  • 1陈晖.重度妊娠高血压综合征合并胎儿生长受限的围生儿结局分析[J].中国医药,2006,1(5):310-311. 被引量:6
  • 2许峰,陈红,许闽涛.新生儿缺氧缺血性脑病42例血镁检测及临床意义[J].蚌埠医学院学报,2007,32(1):72-73. 被引量:2
  • 311省市苯丙酮尿症筛查协作组.我国11省市苯丙酮尿症新生儿筛查[J].中华儿科杂志,1985,23:321-323.
  • 4Kim YN, Lee DS, Jeong DH, et al. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenat Diagn,2009,20 (5) :464-470.
  • 5Venkatesha S, Toporsian M, Lain C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med, 2006,12 (6) :642-649.
  • 6Staff AC, Braekke K, Johnsen GM, et al. Circulating concentra tions of soluble endoglin( CD105 ) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol,2007,197 (2) :e1-e6.
  • 7Kanaka-Gantenbein C, Mastorakos G, Chrousos GP. Endocrine-related causes and consequences of intrauterine growth retardation. Ann N Y Acad Sci, 2003, 997:150-157.
  • 8Bischof P, Meisser A, Campana A. Paracrine and autocrine regulators of trophoblast invasion--a review. Placenta,2000,21 Suppl A : 55-60.
  • 9Jeyabalan A, McGonigal S, Gilmour C, et al. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta, 2008,29(6) : 555-563.
  • 10Stepan H, Kraer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab, 2007,92(7) :2831-2834.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部